Alerts will be sent to your verified email
Verify Email
VANTABIO
|
Vanta Bioscience
|
FGP
|
Sterling Internl.Ent
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-9.14 % | -7.13 % | n/a |
|
5yr average Equity Multiplier
|
3.77 | 1.08 | n/a |
|
5yr Average Asset Turnover Ratio
|
0.14 | 0.05 | n/a |
|
5yr Avg Net Profit Margin
|
-22.86 % | -30.89 % | n/a |
|
Price to Book
|
0.0 | 2.96 | n/a |
|
P/E
|
0.0 | 47.48 | n/a |
|
5yr Avg Cash Conversion Cycle
|
-2109.35 Days | 0.0 | n/a |
|
Inventory Days
|
349.3 Days | 0.0 | n/a |
|
Days Receivable
|
95.72 Days | 0.0 | n/a |
|
Days Payable
|
977.74 Days | 415.0 Days | n/a |
|
5yr Average Interest Coverage Ratio
|
0.56 | -1325.47 | n/a |
|
5yr Avg ROCE
|
1.17 % | -11.7 % | n/a |
|
5yr Avg Operating Profit Margin
|
16.63 % | -407.41 % | n/a |
|
5 yr average Debt to Equity
|
2.28 | 0.0 | n/a |
|
5yr CAGR Net Profit
|
n/a | n/a | n/a |
|
5yr Average Return on Assets
|
-1.51 % | -6.61 % | n/a |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.36 % | 41.45 % | n/a |
|
Share Pledged by Promoters
|
0.0 | 0.0 | n/a |
|
Change in Promoter Holding (3 Yrs)
|
-3.09 % | 0.0 | n/a |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | n/a |
|
Vanta Bioscience
|
FGP
|
Sterling Internl.Ent
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|